In last trading session, Milestone Pharmaceuticals Inc (NASDAQ:MIST) saw 1.5 million shares changing hands with its beta currently measuring 1.05. Company’s recent per share price level of $1.93 trading at $0.12 or 6.63% at ring of the bell on the day assigns it a market valuation of $102.92M. That closing price of MIST’s stock is at a discount of -42.49% from its 52-week high price of $2.75 and is indicating a premium of 41.97% from its 52-week low price of $1.12. Taking a look at company’s average trading volume for last 10-days demonstrates a volume of 1.57 million shares which gives us an average trading volume of 874.10K if we extend that period to 3-months.
For Milestone Pharmaceuticals Inc (MIST), analysts’ consensus is at an average recommendation of Buy while assigning it a mean rating of 1.40. Splitting up the data highlights that, out of 3 analysts covering the stock, 0 rated the stock as a Sell while 0 recommended an Overweight rating for the stock. 0 suggested the stock as a Hold whereas 3 see the stock as a Buy. 0 analyst(s) advised it as an Underweight. The company is expected to be making an EPS of -0.15 in the current quarter.
Milestone Pharmaceuticals Inc (NASDAQ:MIST) trade information
Upright in the green during last session for gaining 6.63%, in the last five days MIST remained trading in the red while hitting it’s week-highest on Thursday, 03/06/25 when the stock touched $1.93 price level, adding 8.96% to its value on the day. Milestone Pharmaceuticals Inc’s shares saw a change of -18.22% in year-to-date performance and have moved -2.53% in past 5-day. Milestone Pharmaceuticals Inc (NASDAQ:MIST) showed a performance of -13.45% in past 30-days. Number of shares sold short was 0.74 million shares which calculate 0.71 days to cover the short interests.
Wall Street analysts have assigned a consensus price target of 10 to the stock, which implies a rise of 80.7% to its current value. Analysts have been projecting 10 as a low price target for the stock while placing it at a high target of 10. It follows that stock’s current price would drop -418.13% in reaching the projected high whereas dropping to the targeted low would mean a loss of -418.13% for stock’s current value.
Milestone Pharmaceuticals Inc (MIST) estimates and forecasts
This year revenue growth is estimated to fall -100.00% from the last financial year’s standing.
Weighing up company’s earnings over the past 5-year and in the next 5-year periods, we find the company posting an annual earnings growth rate of -7.22% during past 5 years. In 2025, company’s earnings growth rate is likely to be around 54.82% while estimates for its earnings growth in next 5 years are of 26.29%.
Milestone Pharmaceuticals Inc (NASDAQ:MIST)’s Major holders
Insiders are in possession of 0.65% of company’s total shares while institution are holding 46.28 percent of that, with stock having share float percentage of 46.59%. Investors also watch the number of corporate investors in a company very closely, which is 46.28% institutions for Milestone Pharmaceuticals Inc that are currently holding shares of the company. BLACKROCK INC. is the top institutional holder at MIST for having 4.97 million shares of worth $6.56 million. And as of 2024-06-30, it was holding 9.9119 of the company’s outstanding shares.
The second largest institutional holder is RTW INVESTMENTS, LP, which was holding about 3.26 million shares on 2024-06-30. The number of shares represents firm’s hold over 4.9211 of outstanding shares, having a total worth of $4.3 million.
